Table 5 Anti-HFG mAb epitope expression in human cancer cell lines
From: Novel heavily fucosylated glycans as a promising therapeutic target in colorectal cancer
Type | Cell line | anti-HFG mAb binding |
|---|---|---|
Gastric cancer | AGS |  +  +  +  |
|  | TSGH9201 |  +  |
|  | NCI-N87 |  +  +  |
|  | KATO III | − |
|  | MKN45 | − |
|  | MKN74 | − |
|  | MKN7 | − |
Colon cancer | LOVO | − |
|  | COLO 205 | − |
|  | COLO 201 |  +  |
|  | SW1116 |  +  +  +  |
|  | DLD-1 |  +  +  |
|  | LS 174 T |  +  |
|  | HT-29 | − |
|  | T84 | − |
Breast cancer | MCF-7 |  +  +  |
|  | MDA-MB-231 | − |
|  | MDA-MB-453 | − |
|  | T-47D | − |
Ovarian cancer | NIH: OVCAR-3 |  +  |
|  | SW626 |  +  |
|  | SK-OV-3 | − |
|  | ES-2 | − |
Pancreatic cancer | SU.86.86 | − |
|  | EBC-1 | − |
|  | PANC-1 | − |
Lung cancer | NCl-H146 |  +  |
|  | NCl-H209 | − |
Skin cancer | A431 | − |